Cargando…
Alterations of DNA damage repair in cancer: from mechanisms to applications
DNA damage repair (DDR) pathways are essential to ensure the accurate transmission of genetic material. However, different endogenous and exogenous factors challenge genomic integrity. Mechanisms involved in the alterations of DDR pathways mainly include genetic inactivation and epigenetic mechanism...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812211/ https://www.ncbi.nlm.nih.gov/pubmed/33490197 http://dx.doi.org/10.21037/atm-20-2920 |
_version_ | 1783637620943749120 |
---|---|
author | Jiang, Minlin Jia, Keyi Wang, Lei Li, Wei Chen, Bin Liu, Yu Wang, Hao Zhao, Sha He, Yayi Zhou, Caicun |
author_facet | Jiang, Minlin Jia, Keyi Wang, Lei Li, Wei Chen, Bin Liu, Yu Wang, Hao Zhao, Sha He, Yayi Zhou, Caicun |
author_sort | Jiang, Minlin |
collection | PubMed |
description | DNA damage repair (DDR) pathways are essential to ensure the accurate transmission of genetic material. However, different endogenous and exogenous factors challenge genomic integrity. Mechanisms involved in the alterations of DDR pathways mainly include genetic inactivation and epigenetic mechanisms. The development and progression of carcinomas are closely associated with DDR pathway aberrations, including the epigenetic silencing of gene O6-alkylguanine-DNA methyltransferase (MGMT); deficiencies of mismatch repair (MMR) genes, including MutL homolog 1 (MLH1), MutS protein homologue (MSH)-2 (MSH2), MSH6, and PMS1 homolog 2; the mismatch repair system component (PMS2); and mutations of homologous recombination repair (HRR) genes, such as the breast cancer susceptibility gene 1/2 (BRCA1/2). Understanding the underlying mechanisms and the correlations between alterations to DDR pathways and cancer could improve the efficacy of antitumor therapies. Emerging evidence suggests that survival is higher in patients with DDR-deficient tumors than in those with DDR-proficient tumors. Thus, DDR alterations play a predictive and prognostic role in anticancer therapies. Theoretical studies on the co-administration of DDR inhibitors and other anticancer therapies, including chemotherapy, radiotherapy, immunotherapy, endocrine therapy, and epigenetic drugs, hold promise for cancer treatments. In this review, we focus on the basic mechanisms, characteristics, current applications, and combination strategies of DDR pathways in the anticancer field. |
format | Online Article Text |
id | pubmed-7812211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-78122112021-01-22 Alterations of DNA damage repair in cancer: from mechanisms to applications Jiang, Minlin Jia, Keyi Wang, Lei Li, Wei Chen, Bin Liu, Yu Wang, Hao Zhao, Sha He, Yayi Zhou, Caicun Ann Transl Med Review Article DNA damage repair (DDR) pathways are essential to ensure the accurate transmission of genetic material. However, different endogenous and exogenous factors challenge genomic integrity. Mechanisms involved in the alterations of DDR pathways mainly include genetic inactivation and epigenetic mechanisms. The development and progression of carcinomas are closely associated with DDR pathway aberrations, including the epigenetic silencing of gene O6-alkylguanine-DNA methyltransferase (MGMT); deficiencies of mismatch repair (MMR) genes, including MutL homolog 1 (MLH1), MutS protein homologue (MSH)-2 (MSH2), MSH6, and PMS1 homolog 2; the mismatch repair system component (PMS2); and mutations of homologous recombination repair (HRR) genes, such as the breast cancer susceptibility gene 1/2 (BRCA1/2). Understanding the underlying mechanisms and the correlations between alterations to DDR pathways and cancer could improve the efficacy of antitumor therapies. Emerging evidence suggests that survival is higher in patients with DDR-deficient tumors than in those with DDR-proficient tumors. Thus, DDR alterations play a predictive and prognostic role in anticancer therapies. Theoretical studies on the co-administration of DDR inhibitors and other anticancer therapies, including chemotherapy, radiotherapy, immunotherapy, endocrine therapy, and epigenetic drugs, hold promise for cancer treatments. In this review, we focus on the basic mechanisms, characteristics, current applications, and combination strategies of DDR pathways in the anticancer field. AME Publishing Company 2020-12 /pmc/articles/PMC7812211/ /pubmed/33490197 http://dx.doi.org/10.21037/atm-20-2920 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article Jiang, Minlin Jia, Keyi Wang, Lei Li, Wei Chen, Bin Liu, Yu Wang, Hao Zhao, Sha He, Yayi Zhou, Caicun Alterations of DNA damage repair in cancer: from mechanisms to applications |
title | Alterations of DNA damage repair in cancer: from mechanisms to applications |
title_full | Alterations of DNA damage repair in cancer: from mechanisms to applications |
title_fullStr | Alterations of DNA damage repair in cancer: from mechanisms to applications |
title_full_unstemmed | Alterations of DNA damage repair in cancer: from mechanisms to applications |
title_short | Alterations of DNA damage repair in cancer: from mechanisms to applications |
title_sort | alterations of dna damage repair in cancer: from mechanisms to applications |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812211/ https://www.ncbi.nlm.nih.gov/pubmed/33490197 http://dx.doi.org/10.21037/atm-20-2920 |
work_keys_str_mv | AT jiangminlin alterationsofdnadamagerepairincancerfrommechanismstoapplications AT jiakeyi alterationsofdnadamagerepairincancerfrommechanismstoapplications AT wanglei alterationsofdnadamagerepairincancerfrommechanismstoapplications AT liwei alterationsofdnadamagerepairincancerfrommechanismstoapplications AT chenbin alterationsofdnadamagerepairincancerfrommechanismstoapplications AT liuyu alterationsofdnadamagerepairincancerfrommechanismstoapplications AT wanghao alterationsofdnadamagerepairincancerfrommechanismstoapplications AT zhaosha alterationsofdnadamagerepairincancerfrommechanismstoapplications AT heyayi alterationsofdnadamagerepairincancerfrommechanismstoapplications AT zhoucaicun alterationsofdnadamagerepairincancerfrommechanismstoapplications |